{{Drugbox
| Verifiedfields = 
| Watchedfields = 
| verifiedrevid = 
| IUPAC_name = (5''S'',8''R'',9''R'',10''S'',13''S'',14''S'',17''S'')-17-Hydroxy-13-methyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1''H''-cyclopenta[''a'']phenanthren-3-one
| image = 5α-Dihydronandrolone.svg
| width = 225px

<!--Clinical data-->
| tradename = 
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = 
| legal_UK = 
| legal_US = 
| legal_status = 
| routes_of_administration = 

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion = 

<!-- Identifiers -->
| CAS_number_Ref = {{cascite|correct|CAS}}
| CAS_number = 1434-85-1
| CAS_supplemental = 
| ATC_prefix = 
| ATC_suffix = 
| ATC_supplemental = 
| PubChem = 94202
| IUPHAR_ligand = 
| DrugBank_Ref = 
| DrugBank = 
| ChemSpiderID_Ref = 
| ChemSpiderID = 85015
| UNII = I0V6O3097Q
| KEGG = 
| ChEBI = 
| ChEMBL = 3137999
| synonyms = Dihydronandrolone; DHN; 5α-DHN; 5α-Dihydro-19-nortestosterone; 5α-Estran-17β-ol-3-one; 19-nor-5α-androstan-17β-ol-3-one

<!--Chemical data-->
| C=18 | H=28 | O=2
| SMILES = C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CC[C@@H]4[C@@H]3CCC(=O)C4
| StdInChI_Ref = 
| StdInChI = 1S/C18H28O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h11,13-17,20H,2-10H2,1H3/t11-,13-,14+,15+,16-,17-,18-/m0/s1
| StdInChIKey_Ref = 
| StdInChIKey = RHVBIEJVJWNXBU-PNOKGRBDSA-N
| melting_point     = 130-131
| melting_notes = <ref>{{cite journal|journal=Journal of the American Chemical Society|volume=80|issue=22|language=en|issn=0002-7863|date=1958-11|pages=6115–6118|doi=10.1021/ja01555a054|url=https://pubs.acs.org/doi/abs/10.1021/ja01555a054|title=Steroids. CI. 1 19-Nordihydrotestosterone Derivatives 2|accessdate=2021-01-21|author=A. Bowers, H. J. Ringold, E. Denot}}</ref>
}}
'''5α-双氢诺龙'''（{{lang-en|5α-Dihydronandrolone}}，缩写'''5α-DHN'''、'''DHN'''）也被称为'''5α-双氢-19-去甲睾酮'''（5α-dihydro-19-nortestosterone）或'''5α-雌烷-17β-醇-3-酮'''（5α-estran-17β-ol-3-one）是一种[[天然产物|天然]][[同化類固醇|同化類固醇]]（AAS）和[[诺龙|诺龙]]（19-去甲睾酮）的[[5α還原酶|5α還原]][[衍生物|衍生物]]<ref name="Kicman2008">{{cite journal | vauthors = Kicman AT | title = Pharmacology of anabolic steroids | journal = British Journal of Pharmacology | volume = 154 | issue = 3 | pages = 502–21 | date = June 2008 | pmid = 18500378 | doi = 10.1038/bjp.2008.165 | pmc = 2439524 }}</ref>，和[[5α還原酶|5α還原酶]]催化[[睾酮|睾酮]]生成5α-[[双氢睾酮|双氢睾酮]]（DHT）类似，5α還原酶也可催化[[19-去甲睾酮|19-去甲睾酮]]生成5α-双氢诺龙<ref name="Kicman2008" /><ref name="Thomas2012">{{cite book|author=John A. Thomas|title=Drugs, Athletes, and Physical Performance|url=https://books.google.com/books?id=9u0pBgAAQBAJ&pg=PA29|date=6 December 2012|publisher=Springer Science & Business Media|isbn=978-1-4684-5499-4|pages=29–}}</ref>。

==参考文献==
{{Reflist}}

{{Androgen receptor modulators}}

{{DEFAULTSORT:双氢诺龙, 5α-}}

[[Category:雄激素类|Category:雄激素类]]
[[Category:环戊醇|Category:环戊醇]]